Stock Analysis on Net
Stock Analysis on Net

Celgene Corp. (NASDAQ:CELG)

This company has been moved to the archive! The financial data has not been updated since October 31, 2019.

Debt to Equity 
since 2005

Microsoft Excel

Calculation

Celgene Corp., debt to equity, long-term trends, calculation

Microsoft Excel
Debt to equity = Total debt1 ÷ Stockholders’ equity1
Dec 31, 2018 3.29 = 20,270 ÷ 6,161
Dec 31, 2017 2.29 = 15,838 ÷ 6,921
Dec 31, 2016 2.17 = 14,289 ÷ 6,599
Dec 31, 2015 2.41 = 14,250 ÷ 5,919
Dec 31, 2014 1.05 = 6,872 ÷ 6,525
Dec 31, 2013 0.85 = 4,741 ÷ 5,590
Dec 31, 2012 0.54 = 3,080 ÷ 5,694
Dec 31, 2011 0.33 = 1,802 ÷ 5,513
Dec 31, 2010 0.21 = 1,248 ÷ 5,984
Dec 31, 2009 0.00 = — ÷ 4,395
Dec 31, 2008 0.00 = — ÷ 3,491
Dec 31, 2007 0.07 = 197 ÷ 2,844
Dec 31, 2006 0.20 = 400 ÷ 1,976
Dec 31, 2005 0.63 = 400 ÷ 636

Based on: 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

1 US$ in millions

Comparison to Competitors

Celgene Corp., debt to equity, long-term trends, comparison to competitors

Microsoft Excel
Celgene Corp. AbbVie Inc. Amgen Inc. Bristol-Myers Squibb Co. Danaher Corp. Eli Lilly & Co. Gilead Sciences Inc. Johnson & Johnson Merck & Co. Inc. Pfizer Inc. Regeneron Pharmaceuticals Inc. Thermo Fisher Scientific Inc.
Dec 31, 2018 3.29 — 2.71 0.52 0.35 1.30 1.28 0.51 0.94 0.66 0.08 0.69
Dec 31, 2017 2.29 7.33 1.40 0.68 0.40 1.18 1.64 0.57 0.71 0.60 0.11 0.83
Dec 31, 2016 2.17 7.95 1.16 0.41 0.53 0.74 1.39 0.39 0.62 0.71 0.11 0.77
Dec 31, 2015 2.41 8.03 1.12 0.47 0.54 0.55 1.20 0.28 0.59 0.60 0.10 0.59
Dec 31, 2014 1.05 8.62 1.19 0.53 0.15 0.52 0.80 0.27 0.44 0.51 0.18 0.71
Dec 31, 2013 0.85 3.28 1.45 0.55 0.16 0.30 0.58 0.25 0.50 0.48 0.26 0.62
Dec 31, 2012 0.54 4.66 1.39 0.54 0.28 0.37 0.88 0.25 0.39 0.46 0.37 0.46
Dec 31, 2011 0.33 — 1.13 0.34 0.31 0.52 1.13 0.34 0.32 0.47 0.90 0.47
Dec 31, 2010 0.21 — 0.56 0.35 0.21 0.56 0.59 0.30 0.33 0.50 0.31 0.14
Dec 31, 2009 0.00 — 0.47 0.43 0.25 0.70 0.18 0.29 0.30 0.54 0.27 0.14
Dec 31, 2008 0.00 — 0.50 0.55 0.27 1.55 0.31 0.28 0.33 0.30 0.00 0.14
Dec 31, 2007 0.07 — 0.63 0.59 0.41 0.37 0.38 0.22 0.32 0.20 0.43 0.15
Dec 31, 2006 0.20 — 0.48 0.74 0.37 0.34 0.77 0.17 0.39 0.11 0.92 0.19
Dec 31, 2005 0.63 — 0.19 0.77 0.21 0.60 0.10 0.07 0.45 0.27 1.75 0.21

Based on: 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)

Celgene Corp., debt to equity, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)

Microsoft Excel
Celgene Corp. Pharmaceuticals, Biotechnology & Life Sciences
Dec 31, 2018 3.29 0.94
Dec 31, 2017 2.29 0.88
Dec 31, 2016 2.17 0.79
Dec 31, 2015 2.41 0.68
Dec 31, 2014 1.05 0.55
Dec 31, 2013 0.85 0.52
Dec 31, 2012 0.54 0.51
Dec 31, 2011 0.33 0.46
Dec 31, 2010 0.21 0.39
Dec 31, 2009 0.00 0.39
Dec 31, 2008 0.00 0.37
Dec 31, 2007 0.07 0.30
Dec 31, 2006 0.20 0.25
Dec 31, 2005 0.63 0.29

Based on: 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

Comparison to Industry (Health Care)

Celgene Corp., debt to equity, long-term trends, comparison to industry (health care)

Microsoft Excel
Celgene Corp. Health Care
Dec 31, 2018 3.29 0.87
Dec 31, 2017 2.29 0.79
Dec 31, 2016 2.17 0.75
Dec 31, 2015 2.41 0.68
Dec 31, 2014 1.05 0.52
Dec 31, 2013 0.85 0.49
Dec 31, 2012 0.54 0.51
Dec 31, 2011 0.33 0.45
Dec 31, 2010 0.21 0.41
Dec 31, 2009 0.00 0.41
Dec 31, 2008 0.00 0.41
Dec 31, 2007 0.07 0.36
Dec 31, 2006 0.20 0.33
Dec 31, 2005 0.63 0.30

Based on: 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).